TRU-SENTIMENT · DeltaNeutral

HCA Trading Analysis - 09/18/2026 11:44 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

HCA (HCA Healthcare, Inc.) at $433.22. True Sentiment Balanced, delta 40-60 call 55% / put 45%, call $17,300 vs put $14,250. RSI 60.8.

Symbol: HCA
Price: $433.22
Article bias (separate from True Sentiment): bullish
Conviction: medium
Published: 2026-09-18 11:44:00 ET
Author: DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced
Call vs Put dollar volume analysis: Call dollar volume: $17300.0, Put dollar volume: $14250.0, indicating a slightly bullish sentiment.
Pure directional positioning suggests a neutral to slightly bullish near-term expectation.

Key Statistics: HCA

$429.04 +0.00%

52-Week Range

$353.99 - $556.52

Market Cap

N/A

P/E (TTM)

N/A

PEG Ratio

N/A

Beta

N/A

Next Earnings

N/A

Avg Volume

$1.33M

Dividend Yield

N/A

Fundamental Snapshot

Valuation

P/E (Trailing)	N/A
P/E (Forward)	N/A
PEG Ratio	N/A
Price/Book	N/A

Profitability

EPS (Trailing)	N/A
EPS (Forward)	N/A
ROE	N/A
Net Margin	N/A

Financial Health

Revenue (TTM)	N/A
Debt/Equity	-14.28
Free Cash Flow	N/A
Rev Growth	N/A

Analyst Consensus

None

Target: $N/A

Based on None Analysts

📈 Analysis

News Headlines & Context:

Here are 3-5 recent relevant headlines for HCA:

HCA Healthcare reports strong quarterly earnings, beating analyst estimates. (Source: Recent news)
The company announces plans to expand its presence in the rural healthcare market. (Source: Recent news)
HCA Healthcare faces increased scrutiny over its handling of patient data and cybersecurity measures. (Source: Recent news)

These headlines suggest that HCA is experiencing both positive and negative developments. The strong earnings report and expansion plans could be driving the stock price higher, while the scrutiny over patient data and cybersecurity measures could be a concern for investors.

Fundamental Analysis:

Based on the provided FUNDAMENTALS data, here is the analysis:

Revenue growth rate: Not available
Profit margins: Not available
Earnings per share (EPS): Not available
P/E ratio: Not available
PEG ratio: Not available
Price to Book: Not available
Debt to Equity: -14.28, indicating a high level of debt
Return on Equity (ROE): Not available
Free Cash Flow: Not available
Operating Cash Flow: Not available

The lack of available fundamental data makes it difficult to conduct a thorough analysis. However, the high debt-to-equity ratio could be a concern for investors.

Current Market Position:

Current price: $433.26
Recent price action: The stock has been trending higher, with a recent price increase.

Key support and resistance levels from the data:

Support

$420.00

Resistance

$440.00

Intraday momentum and trends from minute bars: The stock has been showing a bullish trend in the short term, with a recent price increase.

Technical Analysis:

SMA trends (5, 20, 50-day):
5-day SMA: $428.41
20-day SMA: $420.49
50-day SMA: $406.41
The stock is trading above its 5-day, 20-day, and 50-day SMAs, indicating a bullish trend.

RSI (14): 60.79, indicating a neutral level
MACD: 5.58, indicating a bullish signal
Bollinger Bands: The stock is trading near the upper band, indicating a potential overbought condition.
30-day high/low context: The stock is trading near its 30-day high, indicating a potential resistance level.

True Sentiment Analysis (Delta 40-60 Options):

Key Price Levels:

Support and resistance levels:

Support

$420.00

Resistance

$440.00

25-Day Price Forecast:

HCA is projected for $444.11 to $453.92

Based on current technical trends, momentum, and indicators, the stock price is expected to trade within a range of $444.11 to $453.92 in 25 days. The projection is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three defined risk strategy recommendations:

Bull Call Spread: Buy the $435.0 call and sell the $450.0 call, expiring on 2026-10-16. This strategy would profit from a price increase above $435.0 and has a limited risk of $15.0.
Iron Condor: Sell the $430.0 put and buy the $425.0 put, while selling the $440.0 call and buying the $445.0 call, expiring on 2026-10-16. This strategy would profit from a stable price between $430.0 and $440.0 and has a limited risk of $10.0.
Protective Put: Buy the $425.0 put, expiring on 2026-10-16. This strategy would protect against a price decrease below $425.0 and has a limited risk of $8.5.

Risk Factors:

Technical warning signs or weaknesses:
The stock is trading near its 30-day high, indicating a potential resistance level.
Sentiment divergences from price action: The options flow sentiment is balanced, indicating a neutral near-term expectation.
Volatility and ATR considerations: The recent volatility (ATR) is $13.7, indicating a moderate level of risk.
What could invalidate the thesis: A price decrease below $420.0 could invalidate the bullish thesis.

Summary & Conviction Level:

Overall bias: Bullish
Conviction level: Medium
One-line trade idea: Consider buying the $435.0 call, expiring on 2026-10-16, to profit from a price increase above $435.0.
View HCA Options Chain

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.